PMID: 16640227Apr 28, 2006Paper

Characteristics of autologous peripheral blood stem cells in pediatric patients

Lijec̆nic̆ki vjesnik
Ines BojanićBoris Labar

Abstract

Autologous peripheral blood stem cells are increasingly used for transplantation instead of bone marrow, even in small children and adolescents. We analyzed 73 autologous leukaphereses performed in 25 children (36% males, 64% females). The median age was 15 years (range 3-18) and the median body weight 48 kg (range 16-67). The apheresis procedures were carried out with cell separator COBE Spectra. Each patient underwent a median of 2 collections (range 1-6). The median total nucleated cell yield was 11.86x108/kg (range 1.94-21.21), mononuclear cell yield was 6.01x10(8)/kg (range 0.97-12.73) and CD34+ cell yield was 3.5 x10(6)/kg (range 0.19-28.01). During 6 (8.22%) procedures the patients had experienced apheresis-related side effects. The citrate-induced reactions were most commonly observed. The reactions were mild and cessation of collection was required only in one case, because of catheter related complication. Our results show that leukapheresis in pediatric patients is a safe procedure, well tolerated and with a very low risk of serious adverse events.

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.